Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-11 Sale |
2023-12-11 8:00 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
886 | $9.1301 | $8,089 | 1,997 (Direct) |
View |
| 2023-06-16 Purchase |
2023-06-21 4:04 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
3,350,000 | $8.12 | $27,202,000 | 13,437,473 (Indirect) |
View |
| 2023-03-28 Purchase |
2023-03-30 5:47 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
200,000 | $8 | $1,600,000 | 10,087,473 (Indirect) |
View |
| 2023-03-10 Sale |
2023-03-14 5:00 pm |
Zymeworks Inc. | ZYME | Klompas Neil A President & COO |
2,977 | $7.8259 | $23,298 | 20,441 (Indirect Direct) |
View |
| 2023-01-19 Purchase |
2023-01-23 6:00 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
307,500 | $9.6999 | $2,982,733 | 9,887,473 (Indirect) |
View |
| 2023-01-13 Purchase |
2023-01-18 6:27 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
985,100 | $9.8442 | $9,697,527 | 9,579,973 (Indirect) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:47 pm |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
1,026,300 | $7.6723 | $7,874,083 | 8,594,873 (Indirect) |
View |
| 2022-12-12 Sale(A) |
2022-12-23 8:00 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
887 | $6.01 | $5,331 | 2,883 (Direct) |
View |
| 2022-11-10 Sale(A) |
2022-12-23 8:00 pm |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
2,475 | $8.099 | $20,045 | 26,221 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 8:00 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
887 | $6.01 | $5,331 | 2,883 (Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 9:41 pm |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
2,475 | $8.099 | $20,045 | 26,221 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-05 Option Award |
2024-01-08 6:00 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2024-01-05 6:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Smith Jeffrey T L EVP & Chief Medical Officer |
0 | $0 | 188,000 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-11 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
1,550 | $0 | 1,997 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:48 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Campoy Carlos Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:41 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | RENTON HOLLINGS Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:26 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Neu Kelvin Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:26 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Cox Troy Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:22 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Mahony Susan Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:20 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Miller Derek John Michael Director |
37,000 | $0 | 37,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:18 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Davidson Nancy Director |
74,000 | $0 | 74,000 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-08 5:17 pm |
N/A 2033-12-06 |
Zymeworks Inc. | ZYME | Hillan Kenneth J. Director |
37,000 | $0 | 37,000 (Direct) |
View |
Ownership |
2023-12-08 5:03 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Davidson Nancy Director |
0 | $0 | 0 (Direct) |
View |
| 2023-06-30 Option Award |
2023-06-30 8:05 pm |
N/A 2033-06-29 |
Zymeworks Inc. | ZYME | Campoy Carlos Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2023-06-30 8:03 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Campoy Carlos Director |
0 | $0 | 0 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-10 8:10 pm |
N/A 2033-04-09 |
Zymeworks Inc. | ZYME | Miller Derek John Michael Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2023-04-10 8:05 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Miller Derek John Michael Director |
0 | $0 | 0 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Klompas Neil A President & COO |
5,208 | $0 | 20,441 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Klompas Neil A President & COO |
146,000 | $0 | 146,000 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
78,500 | $0 | 78,500 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
358,000 | $0 | 358,000 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Moore Paul Andrew Chief Scientific Officer |
129,000 | $0 | 129,000 (Direct) |
View |
| 2022-12-12 Exercise(A) |
2022-12-23 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
1,550 | $0 | 2,883 (Direct) |
View |
| 2022-11-10 Exercise(A) |
2022-12-23 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
5,885 | $0 | 26,221 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-23 7:30 pm |
2025-12-22 2025-12-22 |
Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | Sacks Natalie Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | Mahony Susan Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | Cox Troy Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | Zoth Lota S. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | Neu Kelvin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | Hillan Kenneth J. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-23 7:00 pm |
N/A 2032-12-20 |
Zymeworks Inc. | ZYME | RENTON HOLLINGS Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
1,550 | $0 | 2,883 (Direct) |
View |
| 2022-11-10 Exercise |
2022-11-14 9:41 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Josephson Neil Chief Medical Officer |
5,885 | $0 | 26,221 (Direct) |
View |
Ownership |
2022-11-01 3:23 pm |
N/A N/A |
Zymeworks Inc. | ZYME | EcoR1 Capital LLC 10% Owner |
0 | $0 | 7,568,573 (Indirect) |
View |